Bedfont Scientific’s NObreath FeNO monitor has been cleared by the US Food and Drug Administration (FDA).
Launched in September, the NObreath FeNO monitor is a portable, non-invasive device for the measurement of Fractional Exhaled Nitric Oxide (FeNO) in human breath.
Offering a quick and non-invasive process, the NObreath FeNO measures FeNO through breath analysis.
Nitric oxide is often found to be increased in inflammatory conditions such as asthma.
... to continue reading you must be subscribed
